InsiderStreet Equity Research

Produced by InsiderStreet.ai from live production data. It is not investment advice, not an offer or solicitation to buy or sell any security, and not a recommendation for any investor. Do not rely on it for any investment decision.

Last Close

$426.70

2026-10-16

Market Cap

$150.7B

Volume

2.6M

52-Wk High

$603.88

52-Wk Low

$328.57

Trailing PE

48.2

P/S

13.66

Gross Margin

66.7%

Net Margin

28.4%

ROE

18%

ROIC

15%

Piotroski

7/9

Altman Z

37.1

1-Yr Return

-1.8%

5-Yr Return

+157.1%

Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.

SectorHealthcareIndustryMedical - Instruments & SuppliesExchangeNASDAQMarket Cap$150.7BEmployees17,021 (SEC-filed)CEODavid J. RosaIPO2000-06-16CountryUS

1020 Kifer Road, Sunnyvale, CA 94086-5304 · Tel 408 523 2100 · intuitive.com

INSIDERSTREET SCORE80 / 100Street mean $433.74 (6 analysts, last qtr) — their number, not ours

INSIDER CONSENSUS SIGNALROUTINE SELLING — LOW SIGNAL$14M sold / 6 mo, zero open-market buys

1 Year vs S&P 500 · ISRG -1.8% · S&P 500 +15.9% · spread -17.7pp

7 Years vs S&P 500 · ISRG +157.1% · S&P 500 +189.9% · spread -32.7pp

Both charts indexed to 100 at the start of their window and drawn on a single shared scale, so the gap to the benchmark is the gap you see. Adjusted closes throughout.

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

INSIDERSTREET
SCORE80of 100

Score Breakdown

Profitability	89/100
Growth	70/100
Momentum	92/100
Quality	91/100
Earnings Quality	76/100
Balance Sheet	96/100
Value	33/100
Risk (safety)	100/100
Overall	80.1/100

Each component is a diagnostic reading on its own 0-100 scale. The overall score is computed separately from the underlying financials and is not the average of the rows above — components are not equally weighted and three of them (Momentum, Value, Risk) are derived partly from price rather than from the business.

Peer Comparison — IS Score

Symbol	IS Score
BDX	43
RMD	82
MDLN	43
WST	72
HOLX	56
DHR	65
ISRG	80

IS Score Trend — quarterly

14 quarters, 23 Q1 to 26 Q2. Peak 80 in 26 Q2, latest 80 — +0 since. Fell in 0 of the last 4 quarters. Dashed line marks 40 on the 0-100 scale.

BUSINESS QUALITY80 / 100IS Score 80.1 / 100 · +0.0 from peak of 80

Fundamental factor model, quarterly. Measures how the business is doing - not where the price is going.

PRICE STRUCTUREBULLISHTechnical Score 82 / 100 · Power +64 · 20 of 22 indicator votes bullish

Vote share across trend, momentum, volume, volatility and pattern families. Describes where the price is, not where it is going.

Both readings sit above the midpoint — business quality at 80 and price structure at 82 out of 100 — so they are not in conflict. The fundamentals and the tape are saying the same thing, which is the case in which either one alone would have been enough.

Trigger	Where it stands now	What it would mean
IS Score reaches 75 and holds two consecutive quarters	now 80.1	would move us up one band
IS Score stops falling - one quarter higher than the prior	last four: 77 → 78 → 79 → 80	the direction matters more than the level
Technical vote share back above 50%	now 82%	price structure no longer broken
Institutional holder count rises two quarters running	peak 2,394 → now 2,249	fewer institutions willing to hold is our clearest warning

We publish these so the view can be shown to be wrong. If none of them move and our reading does, we owe you an explanation.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

This page is InsiderStreet's own reading, produced from the data in the rest of this document. It is not a price target and not investment advice. Analyst consensus and street price targets appear later under their own heading and are the street's numbers, not ours.

Site Convergence Score3 of 4top 4% of 29,420 symbols

Sources Aligned— of 3independent disclosures

Congress (180d)5 buys2026-09-25

Insider Buys (180d)0none disclosed

ETF Funds (30d)1377 up / 1227 downnet +150 funds

Institutions Added (13F)-57managers opening or increasing

Congressional and insider figures are disclosed purchases in the trailing 180 days; ETF figures are COUNTS OF FUNDS whose holding changed in 30 days, not dollars. Coincidence of separate disclosures, not coordination. An absent source means nothing qualifying was disclosed in its window.

Institutions holding — 12 quarters

Peak 2,394 · latest 2,249 (-145 from peak).

Quarter	Holders	13F shares	Value	Reported own%
2026 Q2	2,249	308.4M	$117.0B	87.0%
2026 Q1	2,306	295.9M	$129.4B	83.5%
2025 Q4	2,394	304.2M	$161.0B	85.8%
2025 Q3	2,095	292.7M	$123.1B	82.6%
2025 Q2	2,246	305.6M	$155.3B	86.2%
2025 Q1	2,172	302.6M	$140.9B	85.3%
2024 Q4	2,115	303.6M	$148.5B	85.7%
2024 Q3	1,937	301.3M	$137.9B	85.0%
2024 Q2	1,807	303.7M	$126.1B	85.7%
2024 Q1	1,729	299.4M	$111.0B	84.4%
2023 Q4	1,659	295.2M	$92.6B	83.3%
2023 Q3	1,537	293.3M	$79.8B	82.7%

How to read ownership above 100%. A 13F reports the positions a manager has investment discretion over, and where two or more managers share discretion over the same block, each one reports it. Summed across filers, the total can therefore exceed the shares actually outstanding without anything being wrong. We publish the figure as filed rather than netting it down, and flag separately any quarter where the arithmetic is not merely high but impossible.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Insider	Role	Date	Type	Shares	Value	Post-Txn Owned
Loeb Gary	EVP & Chief Legal and Complian	2026-10-10	EXERCISE	2,612	—	7,932
Loeb Gary	EVP & Chief Legal and Complian	2026-10-10	TAX W/H	1,296	$0.55M	6,636
Loeb Gary	EVP & Chief Legal and Complian	2026-10-10	EXERCISE	2,612	—	0
Wadors Patricia L	SVP Chief Human Resources Offi	2026-10-10	EXERCISE	2,140	—	2,140
Wadors Patricia L	SVP Chief Human Resources Offi	2026-10-10	TAX W/H	1,062	$0.45M	1,078
Wadors Patricia L	SVP Chief Human Resources Offi	2026-10-10	EXERCISE	2,140	—	4,279
Widman Fredrik	VP Corporate Controller	2026-09-15	EXERCISE	546	$0.04M	1,572
Widman Fredrik	VP Corporate Controller	2026-09-15	SELL	543	$0.20M	1,026

6-mo decomposition (Form 4)	Txns	Shares	Value	Signal weight
S — Open-market sales	46	32,149	$14.2M	Counted
M — Exercises (paired A/D)	53	156,488	$0.2M	None — mechanics
F — Tax withholding	40	73,554	$36.8M	None — compensation
P — Open-market purchases	0	0	$0	Counted — none occurred

Monthly Net Insider Flow (000 shares)

Net of acquisitions minus dispositions, all Form 4 types.

Signal Summary

SignalRoutine Selling — Low Signal

Open-Market Sells$14.2M46 txns / 6 mo

Open-Market Buys$0.0M0 txns / 6 mo

ClusterNone active3+ insiders / 21 days

Filed	Filer	Shares registered	Est. proceeds
2026-09-15	Fredrik Widman	2,178	$0.8M
2026-09-08	Mark Brosius	694	$0.3M
2026-08-11	Guthart Family Trust	20,095	$7.9M
2026-08-10	Gary Loeb	400	$0.2M
Trailing 12 mo	44 filings	260,243	$132M

Filed	Form	Reporting person	% of class	Shares
2026-04-30	SCHEDULE 13G	Vanguard Capital Management	7.49%	26.6M sh
2026-03-27	SCHEDULE 13G/A	The Vanguard Group	—	exit/reporting change

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Member	Chamber	Trade	Size band	Traded	Disclosed
Ro Khanna	House	BUY	$1,001 - $15,000	2026-09-25	2026-10-09
Ro Khanna	House	BUY	$1,001 - $15,000	2026-09-11	2026-10-09
Ro Khanna	House	BUY	$1,001 - $15,000	2026-09-04	2026-10-09
Markwayne Mullin	Senate	BUY	$15,001 - $50,000	2025-12-29	2026-01-16
Markwayne Mullin	Senate	BUY	$15,001 - $50,000	2025-12-29	2026-01-15
Markwayne Mullin	Senate	BUY	$50,001 - $100,000	2025-09-24	2025-10-01

House 12-Mo21 trades16 purchases

Senate 12-Mo5 trades5 purchases

CoverageSTOCK Act filings30-45 day disclosure lag

13F Filers (last complete Q)2,306

13F Shares296M83.5% of shares out

New / Closed184 / 236positions, QoQ

Increased / Reduced993 / 821positions, QoQ

Put/Call (13F)1.00option positions

Free Float99.4%351M sh

2.8 · Largest Reporting 13F Managers

Manager	Shares	Value
Assenagon Asset Management S.A.	1.6M	$634M
Sarasin & Partners Llp	290,696	$118M
Wealth Enhancement Advisory Servic	174,342	$65M
Seilern Investment Management Ltd	133,918	$54M
Gateway Investment Advisers Llc	117,866	$48M
Fjarde Ap-Fonden /Fourth Swedish N	117,314	$48M

EDGAR 13F holdings as of 2026-09-30; filer values normalized to dollars.

2.9 · Top ETF & Fund Ownership

Fund	Weight	Position
VITSX	0.2%	$4.6B
VSMPX	0.2%	$4.6B
VTSAX	0.2%	$4.6B
VTI	0.2%	$4.6B
VOO	0.2%	$3.8B
VFIAX	0.2%	$3.8B

13F Filers Holding ISRG — quarterly

Institutional Put/Call — quarterly

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Daily short-sale volume as % of volume reported in FINRA's short-sale file — a flow measure, not short interest; dashed = 50-day average.

Latest Session42.7%2026-10-15

20-Day Avg52.6%50-day 52.4%

TrendRising20d vs 50d

By Market CenterQ: 42% · N: 63% · B: 50%latest session

Weekly Notional ($B)

Where ISRG Trades in the Dark

ATS Venue (4-wk)	Shares	Avg trade
Incr Intelligent Cross Llc	2.5M	26 sh
Ubsa Ubs Ats	2.1M	29 sh
Sgmt Sigma X2	1.2M	24 sh
Ebxl Level Ats	1.0M	16 sh
Mspl Ms Pool (Ats-4)	0.8M	69 sh
Mlix Instinct X	0.8M	33 sh

Where a dollar of Intuitive Surgical, Inc. revenue goes. All values FY2025 filings, live.

Region	Revenue	Share
Geographic Distribution, Domestic	$6.8B	68%
Geographic Distribution, Foreign	$3.2B	32%

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

ISRG (live moat model)Peer median: BDX · RMD · MDLN · WST · HOLX

Component scores from the live moat model. Peer median illustrative.

Moat score 80/100 — Wide; primary source Efficient Scale.

3.8 · Employees (SEC filings)

Officer	Title
David J. Rosa	Chief Executive Officer & Director
Gary S. Guthart	Executive Chair
Jamie E. Samath	Executive VP, CFO & Enterprise Technology Leader
Henry L. Charlton	Senior VP of Global Business Operations

Revenue ($B)

EPS ($) — GAAP diluted actual, street-basis estimate

Actual bars are GAAP diluted EPS from the filed income statement; the lighter forward bars are street-basis consensus. The two are different measures and are not comparable quarter to quarter.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Quarterly EPS — Actual vs. Consensus

Beats (>2%)6 of 6recent quarters

Avg Surprise+12.1%

Next Report2026-10-20

Income Quality1.18OCF ÷ net income

Beat Rate—%0 of 0 quarters

Current Streak0longest 0

Avg EPS Surprise—%median —%

Surprise Trend—last 4 vs prior 4

Period	EPS est.	EPS actual	EPS surprise	Rev est. ($M)	Rev actual ($M)	Rev surprise

Announcement dates to . Consensus as it stood at each report. Revenue surprise shown where both estimate and actual are filed. A beat record is history, not a forecast.

Profit Margins (%)

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Revenue by Segment — Stacked

Live segmentation data.

YoY Growth Heatmap — Income Lines

YoY growth	FY21	FY22	FY23	FY24	FY25
Revenue	+31.0%	+9.0%	+14.5%	+17.2%	+20.5%
Gross profit	+38.4%	+6.0%	+12.7%	+19.1%	+17.9%
Operating income	+73.5%	-13.4%	+12.0%	+32.9%	+25.4%
Net income	+60.7%	-22.4%	+36.0%	+29.2%	+23.0%

$B · FY ends	FY21	FY22	FY23	FY24	FY25
Revenue	5.7	6.2	7.1	8.4	10.1
Cost of revenue	1.8	2.0	2.4	2.7	3.4
Gross profit	4.0	4.2	4.7	5.6	6.6
R&D expense	0.7	0.9	1.0	1.1	1.3
SG&A expense	1.5	1.7	2.0	2.1	2.4
Operating income	1.8	1.6	1.8	2.3	2.9
EBITDA	2.1	1.9	2.2	2.8	3.6
D&A	0.3	0.4	0.4	0.5	0.7
Pretax income	1.9	1.6	2.0	2.7	3.3
Income tax	0.2	0.3	0.1	0.3	0.4
Net income	1.7	1.3	1.8	2.3	2.9
Diluted EPS ($)	4.66	3.65	5.03	6.42	7.87
Diluted shares (M)	366	362	357	362	363

Operating CF$3B

CapEx$1B

Free cash flow$2B

SBC$1B

Buybacks$2B

Net cash change$1B

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Balance Sheet — Full

$B	FY22	FY23	FY24	FY25
Cash & equivalents	1.6	2.8	2.0	3.4
ST investments	2.5	2.5	2.0	2.6
Receivables (net)	1.1	1.3	1.4	1.6
Total current assets	6.3	7.9	7.1	9.8
PP&E (net)	2.4	3.5	4.8	5.3
Goodwill + intangibles	0.4	0.4	0.4	0.4
Total assets	13.0	15.4	18.8	20.6
Accounts payable	0.1	0.2	0.2	0.3
Short-term debt	0.0	0.0	0.0	0.0
Deferred revenue	0.4	0.4	0.5	0.5
Total current liabilities	1.4	1.7	1.7	2.0
Long-term debt	0.0	0.0	0.0	0.1
Total liabilities	1.9	2.0	2.3	2.7
Shareholders' equity	11.1	13.4	16.5	17.9

Cash Flow Statement — Full

$B	FY22	FY23	FY24	FY25
Net income	1.3	1.8	2.3	2.9
D&A	0.4	0.4	0.5	0.7
Stock-based compensation	0.5	0.6	0.7	0.8
Working capital change	(0.6)	(0.8)	(0.9)	(1.3)
Operating cash flow	1.5	1.8	2.4	3.0
Capital expenditures	(0.5)	(1.1)	(1.1)	(0.5)
Investing cash flow	1.4	(0.4)	(3.3)	0.7
Buybacks	(2.6)	(0.4)	0.0	(2.3)
Dividends paid	0.0	0.0	0.0	0.0
Debt issuance / (repay)	0.0	0.0	0.0	0.0
Financing cash flow	(2.6)	(0.3)	0.2	(2.4)
Free cash flow	1.0	0.7	1.3	2.5

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Balance Sheet Structure ($B)

Cash Generation vs Capex ($B)

Left: what the balance sheet is made of — the gap between the assets bar and the liabilities bar is book equity. Right: whether the capex bar is covered by the operating-cash bar; where it is not, the difference was funded externally and free cash flow goes negative.

Ratio	FY21	FY22	FY23	FY24	FY25	TTM
PROFITABILITY
ROE	15.7%	11.5%	14.8%	15.6%	16.7%	18%
ROA	13.8%	10.0%	12.7%	13.6%	14.5%	15.0%
ROIC	21.3%	19.1%	20.3%	16.3%	21.0%	15.1%
Gross margin	69.3%	67.4%	66.4%	67.5%	66.0%	66.7%
Operating margin	31.9%	25.3%	24.8%	28.1%	29.3%	31.3%
Net margin	29.9%	21.3%	25.2%	27.8%	28.4%	28.4%
EBITDA margin	37.3%	31.2%	30.4%	33.7%	36.0%	41.1%
FCF margin	30.4%	15.4%	10.5%	15.6%	24.7%	—
VALUATION
P/E	77.44	71.64	67.21	81.78	71.47	48.2
P/B	11.05	8.58	9.08	11.56	11.45	8.3
P/S	23.12	15.22	16.96	22.74	20.28	13.66
P/FCF	76.05	98.84	161.21	145.68	81.95	46.8
EV/EBITDA	60.00	46.64	52.83	66.20	52.20	32.6
EV/Revenue	22.39	14.56	16.23	22.28	19.72	13.4
Earnings yield	1.3%	1.4%	1.5%	1.2%	1.4%	2.08%
FCF yield	1.3%	1.0%	0.6%	0.7%	1.2%	2.14%

Ratio	FY21	FY22	FY23	FY24	FY25	TTM
LEVERAGE & SOLVENCY
Current ratio	5.08	4.40	4.76	4.07	4.87	4.96
Quick ratio	4.57	3.77	4.02	3.22	3.96	3.91
Debt / equity	0.01	0.00	0.00	0.01	0.02	0.01
Debt / assets	0.6%	0.0%	0.0%	0.8%	1.5%	0.8%
Net debt / EBITDA	-1.94	-2.12	-2.39	-1.38	-1.48	-0.61
Interest coverage	—	—	—	—	—	—

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Ratio	FY21	FY22	FY23	FY24	FY25	TTM
EFFICIENCY
Asset turnover	0.46	0.47	0.50	0.49	0.51	0.53
Receivables turnover	8.00	7.21	6.88	7.09	7.31	6.2
DSO (days)	46	51	53	51	50	59
DPO (days)	21	24	26	26	24	28
Cash conversion cycle	148	160	189	208	204	233
GROWTH (YoY)
Revenue growth	31.0%	9.0%	14.5%	17.2%	20.5%	—
Net income growth	60.7%	-22.4%	36.0%	29.2%	23.0%	—
EPS growth	58.9%	-20.2%	35.5%	27.2%	24.2%	—
FCF growth	51.8%	-44.8%	-21.8%	73.9%	91.0%	—
PER SHARE ($)
EPS (diluted, TTM)	4.64	3.70	5.02	6.38	7.92	8.85
Book value / share	32.53	30.93	37.15	45.16	49.46	51.62
Revenue / share	15.54	17.43	19.89	22.95	27.93	31.13
FCF / share	4.72	2.68	2.09	3.58	6.91	9.09
Cash / share	11.52	11.53	14.58	11.03	16.47	14.71
SHAREHOLDER RETURN & SCORES
Buyback yield	0.0%	2.8%	0.3%	0.0%	1.1%	2.50%
Altman Z-Score	51.17	32.24	37.22	51.06	47.45	37.1
Piotroski F-Score	6	6	6	6	7	7/9
Beneish M-Score	-2.13	-2.47	-2.35	-2.17	-2.40	-2.41

Model	Score	Zone	Note
Piotroski F-Score	7 / 9	Strong
Altman Z-Score	37.1	Safe (>2.99)	Safe
Income quality	1.18	Cash-backed	OCF ÷ net income
Beneish M-Score	-2.41	Non-manipulator	vs −2.22 threshold

DuPont Decomposition (TTM)	Value
Tax burden	0.82
Interest burden	1.05
Operating margin	32.9%
Asset turnover	0.54×
Financial leverage	1.14×
= ROE	17%

Growth Quality (live)	Value
Revenue stability	0.95
Earnings stability	0.81
Earnings persistence	0.92
Revenue CAGR 3y	18.3%
EPS CAGR 3y	30.0%
FCF CAGR 3y	39.8%

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Buyback Yield2.50%

Dividend Yield0.00%none paid

Total Shareholder Return2.25%cash yield

SBC / Revenue7.5%dilution pressure

Company	Mkt cap	P/E	ROE	Net margin	Rev growth	Piotroski	1-yr ret
BDX	$52.2B	57.8	4%	7.6%	-2.6%	6/9	+4.0%
RMD	$33.6B	22.9	24%	26.2%	+9.9%	7/9	-11.3%
MDLN	$31.5B	41.8	3%	0.8%	—	4/9	-12.3%
WST	$27.0B	48.8	19%	17.7%	+12.4%	9/9	+43.8%
HOLX	$17.0B	30.3	11%	17.1%	+2.2%	6/9	—
DHR	$161.0B	40.5	8%	13.9%	+4.6%	6/9	—
PFE	$168.6B	39.1	5%	-1.6%	-0.2%	7/9	—
VRTX	$126.7B	28.9	24%	33.0%	+10.6%	6/9	—

1-yr returns computed from adjusted price history; peers without a tracked series show —.

Buy

57 Analysts

Str Sell (0)Sell (5)Hold (12)Buy (40)Str Buy (0)

Mean Target (qtr)$433.746 targets

Target vs. Price+1.6%last-quarter mean

Next Report2026-10-20street $2.65

Consensus estimates	Revenue mean	High / Low	EPS mean	High / Low	# EPS est.
FY2026	$11.76B	$11.84B / $11.63B	$10.80	$10.96 / $10.44	16
FY2027	$13.27B	$13.92B / $12.88B	$12.10	$12.68 / $11.83	16
FY2028	$15.02B	$16.25B / $13.66B	$13.62	$14.63 / $12.22	7

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Street Price Target — Trajectory

Window	Avg Target	vs. Price	# Targets
Last Month	$451.33	+5.8%	3
Last Quarter	$433.74	+1.6%	6
Last Year	$562.75	+31.9%	47
All Time	$472.63	+10.8%	117

Rolling mean of published targets vs. last close $426.70. Aggregated from StreetInsider, Benzinga, Pulse 2.0.

Third-Party Composite Rating

B-

DCF

3/5

ROE

4/5

ROA

5/5

Debt/Eq

1/5

P/E

1/5

P/B

1/5

Independent quant composite as of 2026-10-16; components scored 1–5 (5 best). Shown for contrast with the InsiderStreet Score — methodologies differ.

ISRG -1.8% vs S&P 500 +15.9% — spread -17.7pp

Sector — XLV +24.2%

Peer Set — indexed to 100

All series indexed to 100 at the start of the window, adjusted closes.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Candlesticks with SMA 20/50 overlay, Bollinger (20,2σ) band, volume, and Wilder RSI(14) — computed from live daily OHLCV.

Moving Average	Value	Distance	% Distance	Signal
SMA 20	$411.16	+15.54	+3.78%	Above
SMA 50	$391.67	+35.03	+8.94%	Above
SMA 200	$439.63	-12.93	-2.94%	Below
EMA 9	$420.22	+6.48	+1.54%	Above
EMA 21	$409.84	+16.86	+4.11%	Above
EMA 50	$398.85	+27.85	+6.98%	Above
EMA 200	$428.81	-2.11	-0.49%	Below

Series and readings from the nightly technical-indicator history — identical data to the site's ribbon chart. Supertrend segments colored by direction.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

TECHNICAL VERDICTBULLISHPower Score +6420 of 22 indicator votes bullish

Family Scores (site weights)

Trend 30%78

Momentum 25%100

Volume 20%81

Volatility 10%100

Patterns 15%50

This Week82% bullishof 11 price-based votes

4 Weeks Ago73%+9 pts since

12 Weeks Ago0%+82 pts since

ReadImprovingweek-over-week trajectory

Price vs SMA 20$411.16

Price vs SMA 50$391.67

Price vs SMA 200$439.63

EMA 9/21 Cross420.2/409.8

SMA 50/200Death

ADX DirectionADX 16

Supertrend$397

Parabolic SAR$402

SMA Slope1.670

RSI64.7

Stochastic K/D84/84

StochRSI K/D73/71

Williams %R-17

CCI138

TSI vs Signal26.9

CMO29.4

ROC8.87%

OBV SignalAccum

Chaikin MF0.200

MFI60

Force Index4M

Elder Ray Bull24.78

RSI (14)30 oversold · 70 overbought

Stochastic %Kvs %D 84

Money Flowvolume-weighted RSI

ADXtrend strength · <20 weak

Williams %Rinverted scale

Level	Value	Level	Value
Pivot / R1 / R2	$425.76 / $431.99 / $436.11	S1 / S2	$421.64 / $415.41
Bollinger (20,2)	$389.89 – $432.42	Squeeze	Off
52-wk range	$328.57 – $603.88	Off 52-wk high	-29.3%
ATR (14)	$11.10 (2.6%)	Historical vol	25.5%

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

+0.3%Jan50%

+0.2%Feb55%

+2.1%Mar67%

+3.5%Apr70%

+0.2%May55%

+3.4%Jun60%

+6.0%Jul70%

-0.4%Aug40%

-0.2%Sep50%

+4.3%Oct55%

+2.3%Nov75%

+0.8%Dec55%

Sample: 20 years — treat short histories as suggestive, not statistical.

Computed from live weekly prices	ISRG	S&P 500
Weekly volatility (σ, 1y)	5.75%	1.83%
Best / worst week (1y)	+26.8% / -12.4%	—
Max drawdown (5y, monthly)	-46.2%	—
1-week VaR (95%)	-7.5%	—
Beta (5y)	1.47	1.00

ISRG EQUITY WEATHER (LIVE)PARTLY CLOUDY · +25

Trend+33

Momentum+59

Volume+61

Volatility-60

Breadth-30

MARKET REGIME (2026-10-16)NEUTRAL

VIX19.99Normal

Dow TheoryConfirmed Bearish

SPY / QQQ TSI7.2 / 4.7trend strength

Sector Strength46/100breadth average

Average sentiment of 701 stories, weekly buckets, −1 to +1.

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Overall+25.0+35.3 vs industry

Trend+33.5+32.7 vs industry

Momentum+59.1+60.2 vs industry

Volume+61.0+43.9 vs industry

Reading	ISRG	Medical - Instruments & Supplies n=284	Healthcare n=5,272	All US symbols n=70,435
Overall	+25.0	-10.3	-24.0	-20.5
Trend	+33.5	+0.7	-25.6	-21.3
Momentum	+59.1	-1.1	-28.5	-15.8
Volume	+61.0	+17.1	-25.0	-3.8

Trend, momentum and volume are computed per company. Volatility and breadth are market-regime values shared by every symbol in the universe, so they are reported once under Market Regime rather than compared here - a company cannot differ from its sector on a constant.

Executive	Total comp	Structure
David J. Rosa Chief Executive Officer	$21.0M	95% equity+incentive
Gary S. Guthart, Ph.D. Executive Chair of th	$18.1M	93% equity+incentive
Jamie E. Samath Executive Vice President, Ch	$8.4M	92% equity+incentive
Henry L. Charlton Executive Vice President a	$6.2M	89% equity+incentive
Gary H. Loeb Executive Vice President and Ch	$5.6M	89% equity+incentive

Pillar (live disclosure scores)	Score
Environmental	55
Social	51
Governance	63
Composite ESG	56

Composite ESG Trend

Filed	8-K contents	Items
2026-07-27	Bylaws Amendment; Exhibits	5.03,9.01
2026-07-16	Earnings Release; Exhibits	2.02,9.01
2026-05-28	Officer/Director Change; Exhibits	5.02,9.01
2026-05-04	Officer/Director Change; Shareholder Vote; Regulation FD	5.02,5.07,7.01
2026-04-21	Earnings Release; Exhibits	2.02,9.01
2026-03-02	Other Events; Financial Statements and Exhibits	8.01,9.01
2026-01-22	Results of Operations and Financial Condition; Financial Statements an	2.02,9.01
2026-01-14	Results of Operations and Financial Condition; Financial Statements an	2.02,9.01

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Methodology. Every figure originates in InsiderStreet's production data layer and is computed deterministically by the same engines that power insiderstreet.ai. This factsheet contains no model-written text. Sections without underlying data are omitted rather than estimated.

DISCLOSURES. This document is produced by InsiderStreet.ai from live production data. It is not investment advice, not an offer or solicitation to buy or sell any security, and not a recommendation tailored to any person. Data is sourced as of the dates shown and may no longer be current. InsiderStreet.ai is not a registered investment adviser or broker-dealer. Investing involves risk, including loss of principal. Past performance does not guarantee future results. Do not make any investment decision based on this document. © 2026 InsiderStreet.ai — all rights reserved. Redistribution prohibited.

Data domain	Source	Coverage for this report
Price & volume	market_db.historical_prices	52 rows
Fundamentals	income_statements_annual	6 rows · 2020 to 2025
Reported vs consensus	fact/earnings_calendar	24 rows · 2020-10-15 to 2026-07-16
Analyst estimates	dim/forward_estimates	3 rows · 2026-12-31 to 2028-12-31
Institutional ownership (13F)	holdings_db.institutional_ownership_summary	94 rows · 2003 to 2026
Insider transactions (Form 4)	edgar/form4	12 rows · 2026-09-11 to 2026-10-10
Proposed sales (Form 144)	edgar/form144	1 record
Beneficial ownership (13D/G)	edgar/13dg	2 rows · 2026-03-27 to 2026-04-30
Short-sale volume (FINRA)	edgar/short_volume_daily	60 rows · 2026-07-23 to 2026-10-15
Dark pool (ATS, tier 1)	edgar/darkpool_weekly	12 rows · 2026-06-15 to 2026-08-31
ETF & fund holding	etf_holdings_changelog (30d)	1 record
Peer set	stock_peers_dynamic	8 rows
Industry medians	industry_medians	1 record
Congressional trades	congress_db (House + Senate)	1 record
ESG	fact/esg_disclosures	1 record

Method. Every figure in this factsheet is looked up from a named field computed in code. It contains no model-written text.

Not covered. Short interest as a percent of float and days-to-cover are not in this data set — the short-sale figures above are FINRA volume, a flow, and cannot support squeeze or covering analysis. Options positioning and intraday data are also absent. 13F ownership is filed 45 days after quarter end and congressional trades are disclosed on a lag, so both describe a past position, not a current one.

Intuitive Surgical, Inc. (ISRG)

Intuitive Surgical, Inc. (ISRG)

Score Breakdown

Peer Comparison — IS Score

IS Score Trend — quarterly

Intuitive Surgical, Inc. (ISRG)

Institutions holding — 12 quarters

Intuitive Surgical, Inc. (ISRG)

Monthly Net Insider Flow (000 shares)

Signal Summary

Intuitive Surgical, Inc. (ISRG)

2.8 · Largest Reporting 13F Managers

2.9 · Top ETF & Fund Ownership

13F Filers Holding ISRG — quarterly

Institutional Put/Call — quarterly

Intuitive Surgical, Inc. (ISRG)

Where ISRG Trades in the Dark

Intuitive Surgical, Inc. (ISRG)

3.8 · Employees (SEC filings)

Intuitive Surgical, Inc. (ISRG)

Intuitive Surgical, Inc. (ISRG)

Intuitive Surgical, Inc. (ISRG)

Balance Sheet — Full

Cash Flow Statement — Full

Intuitive Surgical, Inc. (ISRG)

Intuitive Surgical, Inc. (ISRG)

Intuitive Surgical, Inc. (ISRG)

Intuitive Surgical, Inc. (ISRG)

Street Price Target — Trajectory

Third-Party Composite Rating

Intuitive Surgical, Inc. (ISRG)

Intuitive Surgical, Inc. (ISRG)

Family Scores (site weights)

Intuitive Surgical, Inc. (ISRG)

Intuitive Surgical, Inc. (ISRG)

Intuitive Surgical, Inc. (ISRG)